Evidence map›Paper›PMID 25302939›Full record

ArticleEpidemiology and infection2015

Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012.

S Y C Tong, L Varrone, M D Chatfield, M Beaman, P M Giffard

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Trial
  3. Trial
  4. mBio · 2026
    Article
  5. Review
  6. Community-associated methicillin-resistantEpidemiology and infection · 2024
    Article
  7. Scabies.Nature reviews. Disease primers · 2024
    Review
  8. Article
  9. Article
  10. Antibiotics (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

S Y C TongMenzies School of Health Research,Darwin,Northern Territory,Australia.ORCID http://orcid.org/0000-0002-1368-8356
L VarroneMenzies School of Health Research,Darwin,Northern Territory,Australia.
M D ChatfieldMenzies School of Health Research,Darwin,Northern Territory,Australia.
M BeamanUniversity of Western Australia,Perth,Western Australia,Australia.
P M GiffardMenzies School of Health Research,Darwin,Northern Territory,Australia.
Menzies School of Health Research · AUThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hospital-based studies have determined high rates of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Indigenous populations. However, there is a paucity of community-based data. We obtained 20 years (1993-2012) of data on S. aureus isolates (N = 20 210) collected from community clinics that provide services for Indigenous communities in the Northern Territory, Australia. Methicillin resistance increased from 7% to 24%, resistance to macrolides remained stable at ~25%, and there was a slight increase in resistance to trimethoprim-sulfamethoxazole. The increase in methicillin resistance is concerning for the Indigenous communities represented by this data, but it is also of significance if virulent MRSA clones emerge and spread more widely from such settings.

Indexed as

Methicillin ResistanceAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChildChild, PreschoolCommunity-Acquired InfectionsDrug Resistance, Multiple, BacterialHumansInfantInfant, NewbornMacrolidesMethicillinMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsMacrolidesMethicillinTrimethoprim, Sulfamethoxazole Drug Combinationtrimethoprim-sulfamethoxazole

Identifiers

PMID25302939
PMCPMC9507213
OpenAlexW2165639556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.